XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   118,664     118,664  
Beginning balance $ 1,734,725 $ 1,722,051 $ 1,429,994 $ 1,418,697 $ 1,722,051 $ 1,418,697
Net income 152,471 135,302 126,251 92,904 $ 287,773 219,155
Foreign currency adjustments 28,085 10,435 (1,313) (19,490)    
Dividends declared (75,702) (74,418) (74,006) (74,065)    
Stock issued for employee benefit plans 5,458 (33,021) 9,943 (10,725)    
Stock-based compensation expense 20,882 23,146 19,572 22,673    
Repurchase of common stock $ (81,532) (48,770)        
Ending balance (in shares) 118,317       118,317  
Ending balance $ 1,784,387 $ 1,734,725 $ 1,510,441 $ 1,429,994 $ 1,784,387 $ 1,510,441
Dividends declared, per share (in dollars per share) $ 0.62 $ 0.62 $ 0.61 $ 0.61    
Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares) 118,958 118,664 117,000 116,768 118,664 116,768
Beginning balance $ 11,896 $ 11,866 $ 11,700 $ 11,677 $ 11,866 $ 11,677
Stock issued for employee benefit plans (in shares) 229 779 262 232    
Stock issued for employee benefit plans $ 23 $ 78 $ 26 $ 23    
Stock-based compensation expense (in shares) 0 0 0 0    
Stock-based compensation expense $ 0 $ 0 $ 0 $ 0    
Repurchase of common stock (in shares) (870) (485)        
Repurchase of common stock $ (87) $ (48)        
Ending balance (in shares) 118,317 118,958 117,262 117,000 118,317 117,262
Ending balance $ 11,832 $ 11,896 $ 11,726 $ 11,700 $ 11,832 $ 11,726
Additional Paid-in Capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance 715,021 775,054 746,998 754,093 775,054 754,093
Stock issued for employee benefit plans (11,827) (83,179) (10,435) (29,768)    
Stock-based compensation expense 20,882 23,146 19,572 22,673    
Ending balance 724,076 715,021 756,135 746,998 724,076 756,135
Retained Earnings            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance 5,847,221 5,786,337 5,639,629 5,620,790 5,786,337 5,620,790
Net income 152,471 135,302 126,251 92,904    
Dividends declared (75,702) (74,418) (74,006) (74,065)    
Ending balance 5,923,990 5,847,221 5,691,874 5,639,629 5,923,990 5,691,874
Accumulated Other Comprehensive Loss            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (99,967) (110,402) (100,436) (80,946) (110,402) (80,946)
Foreign currency adjustments 28,085 10,435 (1,313) (19,490)    
Ending balance (71,882) (99,967) (101,749) (100,436) (71,882) (101,749)
Treasury Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (4,739,446) (4,740,804) (4,867,897) (4,886,917) (4,740,804) (4,886,917)
Stock issued for employee benefit plans 17,262 50,080 20,352 19,020    
Stock-based compensation expense 0 0 0 0    
Repurchase of common stock (81,445) (48,722)        
Ending balance $ (4,803,629) $ (4,739,446) $ (4,847,545) $ (4,867,897) $ (4,803,629) $ (4,847,545)